TABLE I.

Baseline characteristics of the Pulsewatch clinical trial and AF trial participants.

		Clinical Trial	AF Trial
Age (years) (SD)		65.33 (±9.08)	71.86 (±6.69)
Female (%)		41.67%	38.10%
Race, non-white (%)		11.67%	9.52%
Mean ECG AF burden per subject (%) (SD)	Confirmed AF subjects, burden reported by Cardea Solo ECG	3.60% (±1.55%)	52.28% (±22.40%)
Mean clean PPG ratio per subject (%) (SD)		16.17% (±13.10%)	31.71% (±12.69%)
Mean PPG rhythm burden per subject on clean PPG (%) (SD)	NSR	86.72% (±30.60%)	8.19% (±23.67%)
	AF	1.68% (±12.80%)	91.57% (±24.40%)
	PAC/PVC	11.60% (±28.46%)	0.24% (±0.74%)
Mean ECG heart rate on clean PPG (BPM) (SD)	NSR	69.59 (±13.79)	62.00 (±17.75)
	AF	82.57 (±7.29)	77.40 (±12.02)
	PAC/PVC	67.84 (±7.64)	77.77 (±12.32)